Archer Aviation Earnings Report: Archer Aviation (ACHR) will report its Q3 earnings on November 6, highlighting its potential through partnerships and patents, making it an attractive option for investors, particularly via ETFs.
ARKX ETF Overview: The ARK Space Exploration & Innovation ETF (ARKX) includes ACHR, accounting for 5.76% of its holdings, and has generated a 17.98% return over the past three months, with a Moderate Buy consensus rating.
XAR ETF Overview: The SPDR S&P Aerospace & Defense ETF (XAR) also includes ACHR, representing 4.07% of its holdings, and has seen a 13.97% return in the last three months, with a Moderate Buy consensus rating.
Investment Strategy: Investing in ETFs like ARKX and XAR provides indirect exposure to ACHR stock, reducing risk while allowing participation in the aerospace and defense sectors.
Wall Street analysts forecast XAR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for XAR is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Analyst Rating
Wall Street analysts forecast XAR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for XAR is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
0 Hold
0 Sell
Current: 285.330
Low
Averages
High
Current: 285.330
Low
Averages
High
No data
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
